B Kiesewetter
Overview
Explore the profile of B Kiesewetter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiesewetter B, Dafni U, de Vries E, Barriuso J, Curigliano G, Gonzalez-Calle V, et al.
Ann Oncol
. 2023 Jun;
34(9):734-771.
PMID: 37343663
Background: The European Society for Medical Oncology (ESMO)-Magnitude of Clinical Benefit Scale (MCBS) has been accepted as a robust tool to evaluate the magnitude of clinical benefit reported in trials...
2.
Oosting S, Barriuso J, Bottomley A, Galotti M, Gyawali B, Kiesewetter B, et al.
Ann Oncol
. 2022 Dec;
34(4):431-439.
PMID: 36549587
Background: The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) has been developed to grade clinical benefit of cancer therapies. Improvement in quality of life (QoL) is considered...
3.
Kiesewetter B, Riss P, Scheuba C, Raderer M
ESMO Open
. 2022 Jun;
7(3):100516.
PMID: 35688063
No abstract available.
4.
Kiesewetter B, Mazal P, Kretschmer-Chott E, Mayerhoefer M, Raderer M
ESMO Open
. 2022 May;
7(3):100478.
PMID: 35525183
Background: The use of somatostatin analogues (SSAs) has not been formally approved in pulmonary neuroendocrine tumours (NETs) in the absence of positive controlled trials, even though it is recommended as...
5.
Buske C, Dreyling M, Alvarez-Larran A, Apperley J, Arcaini L, Besson C, et al.
ESMO Open
. 2022 Mar;
7(2):100403.
PMID: 35272130
Background: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group. Methods: This...
6.
Kiesewetter B, Riss P, Scheuba C, Raderer M
ESMO Open
. 2021 Jun;
6(3):100183.
PMID: 34091261
Medullary thyroid cancer (MTC) represents a rare neuroendocrine neoplasm originating from neoplastic C-cells in the thyroid gland. While localized disease is potentially curable with an optimized surgical approach, the number...
7.
Gyawali B, de Vries E, Dafni U, Amaral T, Barriuso J, Bogaerts J, et al.
ESMO Open
. 2021 Apr;
6(3):100117.
PMID: 33887690
Background: The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a validated, widely used tool developed to score the clinical benefit from cancer medicines reported in clinical...
8.
Ferreri A, Sassone M, Kiesewetter B, Govi S, Scarfo L, Donadoni G, et al.
Ann Oncol
. 2015 May;
26(8):1760-5.
PMID: 25935794
Background: Clarithromycin displays immunomodulatory and antineoplastic properties. As single agent, this macrolide is associated with tumor responses in anecdotal cases of relapsed/refractory extranodal marginal zone lymphoma (rrEMZL), with a putative...
9.
Blauth M, Richter M, Kiesewetter B, Lange U
Chirurg
. 1999 Dec;
70(11):1225-38.
PMID: 10591759
Introduction: Injuries precede the vast majority of all odontoid pseudarthroses. Because of specific anatomic conditions type II injuries lead more often than other types to non unions. For its development...
10.
Schratt H, Regel G, Kiesewetter B, Tscherne H
Unfallchirurg
. 1996 Sep;
99(9):679-84.
PMID: 9005580
We reporting four cases of HIV infection caused by bone allografts from one donor. All transplantations were performed between November 1984 and January 1985. In all, 12 recipients had bone...